Grant Skrepnek to Antineoplastic Agents
This is a "connection" page, showing publications Grant Skrepnek has written about Antineoplastic Agents.
Connection Strength
0.227
-
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
Score: 0.159
-
Oncologist preferences for health states associated with the treatment of advanced ovarian cancer. Appl Health Econ Health Policy. 2010; 8(4):217-23.
Score: 0.056
-
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer. 2007 May-Jun; 17(3):561-70.
Score: 0.012